BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29864959)

  • 1. Current and future biomarkers in gastric cancer.
    Abbas M; Faggian A; Sintali DN; Khan GJ; Naeem S; Shi M; Dingding C
    Biomed Pharmacother; 2018 Jul; 103():1688-1700. PubMed ID: 29864959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive biomarkers along gastric cancer pathogenetic pathways.
    Panarese I; De Vita F; Ronchi A; Romano M; Alfano R; Di Martino N; Zito Marino F; Ferraraccio F; Franco R
    Expert Rev Anticancer Ther; 2017 May; 17(5):417-425. PubMed ID: 28277834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.
    Carlomagno N; Incollingo P; Tammaro V; Peluso G; Rupealta N; Chiacchio G; Sandoval Sotelo ML; Minieri G; Pisani A; Riccio E; Sabbatini M; Bracale UM; Calogero A; Dodaro CA; Santangelo M
    Biomed Res Int; 2017; 2017():7869802. PubMed ID: 29094049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
    Joo MK; Park JJ; Chun HJ
    World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer.
    Yashiro M; Matsuoka T
    World J Gastroenterol; 2016 Feb; 22(8):2415-23. PubMed ID: 26937130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability.
    Cho J; Lee J; Bang H; Kim ST; Park SH; An JY; Choi MG; Lee JH; Sohn TS; Bae JM; Kang WK; Kim S; Kim KM
    Oncotarget; 2017 Feb; 8(8):13320-13328. PubMed ID: 28076847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric biomarkers: a global review.
    Baniak N; Senger JL; Ahmed S; Kanthan SC; Kanthan R
    World J Surg Oncol; 2016 Aug; 14(1):212. PubMed ID: 27514667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of nanoparticles in diagnosis and theranostics of gastric cancer.
    Li R; Liu B; Gao J
    Cancer Lett; 2017 Feb; 386():123-130. PubMed ID: 27845158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine.
    Wang S; Yuan L
    Biosci Trends; 2016 Jul; 10(3):171-80. PubMed ID: 27251446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contactin 1: A potential therapeutic target and biomarker in gastric cancer.
    Chen DH; Yu JW; Jiang BJ
    World J Gastroenterol; 2015 Sep; 21(33):9707-16. PubMed ID: 26361417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric Carcinoma: Recent Trends in Diagnostic Biomarkers and Molecular Targeted Therapies.
    Majeed W; Iftikhar A; Khaliq T; Aslam B; Muzaffar H; Atta K; Mahmood A; Waris S
    Asian Pac J Cancer Prev; 2016; 17(7):3053-60. PubMed ID: 27509928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic and metabolic prediction of response to therapy in gastric cancer.
    Aichler M; Luber B; Lordick F; Walch A
    World J Gastroenterol; 2014 Oct; 20(38):13648-57. PubMed ID: 25320503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of drugs targeting HER-family signalling in cancer.
    Montemurro F; Scaltriti M
    J Pathol; 2014 Jan; 232(2):219-29. PubMed ID: 24105684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on Biomarkers in Development of Anti-angiogenic Drugs in Gastric Cancer.
    Jia S; Cai J
    Anticancer Res; 2016 Mar; 36(3):1111-8. PubMed ID: 26977006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current advances in targeted therapies for metastatic gastric cancer: improving patient care.
    Aguiar PN; Muniz TP; Miranda RR; Tadokoro H; Forones NM; Monteiro ID; Castelo-Branco P; Janjigian YY; De Mello RA
    Future Oncol; 2016 Mar; 12(6):839-54. PubMed ID: 26838766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug sensitivity testing platforms for gastric cancer diagnostics.
    Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
    J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy.
    Kawakami H; Okamoto I
    Gastric Cancer; 2016 Jul; 19(3):687-95. PubMed ID: 26690587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptors in gastric cancer: Advances and perspectives.
    Ur Rahman MS; Cao J
    World J Gastroenterol; 2016 Feb; 22(8):2475-82. PubMed ID: 26937135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.
    Matboli M; El-Nakeep S; Hossam N; Habieb A; Azazy AE; Ebrahim AE; Nagy Z; Abdel-Rahman O
    World J Gastroenterol; 2016 Jul; 22(26):5896-908. PubMed ID: 27468184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy.
    Graziano F; Mandolesi A; Ruzzo A; Bearzi I; Testa E; Arduini F; Silva R; Muretto P; Mari D; Berardi R; Scartozzi M; Lai V; Cascinu S; Magnani M
    Tumour Biol; 2004; 25(3):106-10. PubMed ID: 15361706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.